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Abstract
Introduction: Trials of complex health interventions often pose difficult methodologic challenges.
The objective of this paper is to assess the extent to which the various development steps of a
cluster randomized trial to optimize antibiotic use in nursing homes are represented in a recently
published framework for the design and evaluation of complex health interventions. In so doing,
the utility of the framework for health services researchers is evaluated.
Methods: Using the five phases of the framework (theoretical, identification of components of the
intervention, definition of trial and intervention design, methodological issues for main trial,
promoting effective implementation), corresponding stages in the development of the cluster
randomized trial using diagnostic and treatment algorithms to optimize the use of antibiotics in
nursing homes are identified and described.
Results: Synthesis of evidence needed to construct the algorithms, survey and qualitative research
used to define components of the algorithms, a pilot study to assess the feasibility of delivering the
algorithms, methodological issues in the main trial including choice of design, allocation
concealment, outcomes, sample size calculation, and analysis are adequately represented using the
stages of the framework.
Conclusions: The framework is a useful resource for researchers planning a randomized clinical
trial of a complex intervention.
Background
Antibiotic use in nursing home residents is an important
public health issue given that 50% to 75% of residents are
exposed to at least one course of antibiotics annually [1–
4]. Such overuse can potentially lead to the development
of multi-drug antibiotic resistant bacteria, drug-related ad-
verse effects, and harmful drug interactions [5–14]. The
appropriate use of antibiotics in this setting is challenging.
The diagnosis of infection in residents of nursing homes
is often difficult, since symptoms may be vague and signs
difficult to elicit [14]. The evaluation of residents is often
made by nursing staff who have varying levels of expertise
and knowledge about infectious diseases. Frequently,
treatment decisions are made by busy clinicians who rely
on nursing assessment as their primary source of informa-
tion. Interventions to optimize antibiotic use in this set-
ting therefore need to directly involve both nurses and
physicians and have the potential for strong "buy-in"
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from these healthcare professionals. Such interventions
are aimed at changing behavior and by necessity will in-
volve multiple components.
Recently, Campbell and colleagues published a frame-
work for the design and evaluation of complex health in-
terventions [15]. Derived from a document drafted by
members of the MRC Health Services and Public Health
Research Board, the paper is based on the premise that a
different construct is required for trials that evaluate com-
plex interventions. Examples include interventions to im-
prove delivery of health services, to change health
professionals' behavior, or to promote health through
strategies aimed at individuals, schools, healthcare facili-
ties, or communities. It is apparent that such trials pose
very different challenges when compared to clinical trials
designed, for example, to assess the efficacy of pharmaco-
logic therapy [16]. Amongst these are the development,
identification, documentation, and reproduction of the
interventions. Although such challenges are well known
[17–19], few published strategies exist for researchers
about to embark on a clinical trial of these interventions.
Campbell et al. propose that the development and evalu-
ation of such complex interventions be considered in a se-
ries of phases, analogous to the sequential phases of drug
development [15].
The design and evaluation framework proposed by Camp-
bell et al. appears to be well suited to interventions for op-
timizing antibiotic use in long-term care facilities. The
objective of this paper is to evaluate the extent to which
the various steps in the development of a cluster rand-
omized trial to optimize antibiotic use in nursing homes
are represented in the framework for the design and eval-
uation of complex health interventions [15]. Often it is
not possible to evaluate complex health interventions,
such as strategies to improve antibiotic use in long-term
care facilities, by randomizing individuals. Cluster rand-
omized trials randomize groups of individuals, healthcare
professionals, or institutions. Applying the development
steps of this trial to the framework proposed by Campbell
and colleagues allows for a formal evaluation of the
framework's utility.
Methods
The five phases of the framework of Campbell et al [15]
include 1) a pre-clinical or theoretical phase, 2) Phase I,
identification of the components of the intervention, 3)
Phase II, definition of the trial and intervention design, 4)
Phase III, methodological issues for the main trial, and 5)
Phase IV, promoting effective implementation of the in-
tervention. Using the framework, the corresponding stag-
es of the nursing home trial development are identified
and described.
Results
Preclinical or theoretical phase
Overview
The purpose of this phase is to determine if the interven-
tion has the potential to have the desired effect. This step
can take into account previous studies demonstrating em-
pirical evidence for the intervention as well as the theoret-
ical basis for the intervention. Review of the theoretical
basis for an intervention may lead to an altered hypothe-
sis and improved specification of "potentially active ingre-
dients" [15].
The first step in the development of the algorithms was to
systematically review the literature for data that could lead
to strategies for reducing antibiotic use. Lower respiratory
infections, urinary infections, and skin and soft tissue in-
fections account for the majority of bacterial infections in
residents of long-term care facilities [1,2,4,14]. No data to
support reducing antibiotics for lower respiratory or skin
infections was located. In contrast, data to support reduc-
ing antibiotic use for urinary indications was found.
Asymptomatic bacteriuria, the presence of bacteria in the
urine in the absence of urinary symptoms, occurs in up to
50% of older institutionalized women and 35% of insti-
tutionalized older men [20]. There are four randomized
controlled trials that demonstrate no benefit in treating
asymptomatic bacteriuria in residents of long-term care
facilities [21–24]. Despite the evidence, one third of all
prescriptions for urinary indications in residents of nurs-
ing homes are for asymptomatic bacteriuria [1]. Accord-
ingly, the algorithms indicate that urine should not be
cultured and antibiotics should not be prescribed in the
absence of clinical features of urinary infection (Figures 1
and 2). The algorithms also consider the increased risk of
urinary infection with indwelling urinary catheters and
with specific urinary symptoms [25–28].
Phase I: defining components of the intervention
Overview
This phase, often inter-related to the previous phase, em-
phasizes modeling or simulation studies to improve un-
derstanding of the components of an intervention. Use of
qualitative research and descriptive studies may help de-
fine components of the intervention. Furthermore, in this
phase potential barriers in trials that seek to change be-
havior may be elicited [15].
In order to assess the potential effectiveness of the two al-
gorithms, we applied them to data from a study assessing
antibiotic use in Ontario chronic care facilities [1]. In this
modeling exercise, we found that the algorithms could re-
duce antibiotic use for urinary indications by 80%. Previ-
ously, we had conducted focus groups among physicians
and nurses who provide care to nursing home residents.
Our objective was to explore the perceptions, attitudes,BMC Health Services Research 2002, 2 http://www.biomedcentral.com/1472-6963/2/13
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and opinions of those involved in the process of prescrib-
ing antibiotics for asymptomatic bacteriuria [29]. Twenty-
two physicians and 16 nurses, each in two focus groups,
participated. Both physicians and nurses emphasized that
there was a wide range of indicators, more subtle than the
classic symptoms of urinary tract infection, that influence
the ordering of cultures and the prescribing of antibiotics.
Because residents in long-term care facilities frequently
have cognitive impairment and are unable to articulate
their symptoms, health care providers rely instead on
signs of more subtle functional and behavioural changes.
Misconceptions about the definition of symptoms of uri-
nary tract infection were also discussed. Although the
nurses participating in the focus groups had learned that
foul-smelling urine alone was not sufficient reason to or-
der a culture, a number of physicians still felt that this was
one of the main reasons why cultures are ordered. Other
key findings included the influence nurses have over phy-
sician prescribing through their description of the clinical
situation, often conveyed over the telephone. Physicians
attributed their use of antibiotics to treat bacteriuria in res-
idents with no urinary symptoms to relatively vague non-
urinary symptoms (e.g. lethargy, change in functional sta-
tus). To these physicians, this meant that such residents
were not in fact "asymptomatic", despite the fact that ab-
sence of urinary symptoms alone was used to define
asymptomatic bacteriuria in the clinical trials [21–24].
This was an important barrier to evidence-based care that
would not have been discovered without using a qualita-
tive approach.
Figure 1
Diagnostic algorithm. This algorithm guides physicians and nurses in the ordering of urine cultures for nursing home residents
with suspected infections.
Diagnostic Pathway
Fever of > 37.9ºC (100 ºF) or 1.5°C (2.4 ºF) increase above baseline
on 2 occasions over the last 12 h ?
2 or more symptoms/signs
of other infection*?
Urinary Catheter ?
Do not order
urine culture
YES
YES
YES
NO
NO
NO
* Respiratory symptoms include increased shortness of breath, increased cough, 
increased sputum production, new pleuritic chest pain.
Gastrointestinal symptoms include nausea/vomiting, new abdominal pain, new onset of diarrhea.
Skin/soft tissue symptoms include new redness, warmth, swelling, purulent drainage.
Do I need to order a urine culture for the resident in my care?
Order a urine culture for
new onset burning urination 
OR  for 2 or more
new or worsening ….
urgency                      frequency
flank pain                   gross hematuria
shaking chills             suprapubic pain
urinary incontinence
Order a urine culture for 1 or more 
of the following:
new onset burning urination (dysuria)
presence of a urinary catheter
new or worsening ….
urgency            frequency
flank pain  gross hematuria
shaking chills   suprapubic pain
urinary incontinence
Order a urine culture for 1 or more
of the following
new CVA tenderness
shaking chills (rigors)
new onset of delirium
¶CVA- Costovertebral angleBMC Health Services Research 2002, 2 http://www.biomedcentral.com/1472-6963/2/13
Page 4 of 8
(page number not for citation purposes)
To assess the factors leading to the ordering of urine cul-
tures, we conducted a prospective survey in four nursing
homes. Nursing staff were asked to complete a brief ques-
tionnaire every time a request for a urine culture was
made. They were asked to specify the signs and symptoms
present at the time the culture was ordered and to specify
who initiated the request for the culture. Physicians, after
they received the results of the urine culture, were asked to
indicate the clinical reasons for their therapeutic decision.
Forty-eight percent of the 545 urine cultures obtained
over six months were ordered by nursing staff and 52% by
physicians. The urine culture was suggested by nursing
staff 56% of the time. For 67% of urine culture orders,
there were no urinary symptoms present at the time the
culture was requested. One in every three urine cultures
ordered resulted in an antibiotic prescription. Of these
prescriptions, one third were for asymptomatic bacteriu-
ria.
Phase II: defining trial and intervention design
Overview
In this phase, the information gathered in phase I is used
to develop the optimum intervention and study design.
The feasibility of delivering the intervention is tested and
the acceptability to healthcare providers and patients is as-
sessed [15].
The diagnostic and treatment algorithms were tested and
further refined in a three-month pilot study conducted in
four nursing homes. Administrators and directors of nurs-
Figure 2
Treatment algorithm. This algorithm allows physicians and nurses to optimize antibiotic use in residents with suspected infec-
tions.
Treatment Pathway
Results of the urine culture ?
Urinary Catheter ?
1 or more of the following?
new CVA (Costovertebral)
tenderness
shaking chills (rigors)
new onset of delirium
fever**
Is there 
new onset burning urination (dysuria) ?
Or  2 or more of the following: 
fever**
new or worsening ….
urgency     frequency
flank pain                  gross hematuria
urinary incontinence suprapubic pain 
shaking chills
YES
No UTI
NO
Does the resident in my care need antibiotic treatment for a symptomatic UTI?
> 105 CFU/mL (positive) OR Pending Negative (no growth or mixed)
If yes, begin antibiotics†
If no, do not treat for UTI †  Stop antibiotics if urine culture is negative or no pyuria
Note: the recommended treatment duration for uncomplicated cystitis in women is 7 days and 7-14 in males. For an uncomplicated pyelonephritis, treatment
duration is 10-14 days.For a complicated cystitis, treatment duration is 10 days.  For a complicated pyelonephritis, treatment duration is  from 14 to 21 days.
** >37.9°C (100 °F) or 1.5°C (2.4 °F) above baseline on 2 occasions over the last 12 hBMC Health Services Research 2002, 2 http://www.biomedcentral.com/1472-6963/2/13
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ing of the homes felt that the algorithms should be intro-
duced to the nursing staff by each facility's infection
control practitioner. To ensure that the infection control
practitioners themselves understood the algorithms, they
were asked to decide whether urine cultures should be ob-
tained and antibiotics ordered for six case-scenarios using
the algorithms. Using this "train the trainer" approach,
the practitioners then conducted brief seminars with reg-
istered nursing staff to introduce the algorithms in their
facilities. This approach was unsuccessful however. Semi-
structured interviews with staff revealed that in two of the
homes there were nurses who were completely unfamiliar
with the algorithms two-thirds of the way into the pilot
study. This led to the development of a standardized 30-
minute presentation of six case-scenarios facilitated by
one of two study investigators. Participation was active,
staff were asked to decide whether to order antibiotics and
urine cultures and to justify their answers using the algo-
rithms. In addition, a video-tape replicating the seminar
material was made and distributed to the nursing homes.
The use of logs to document appropriate adherence to the
algorithms was also piloted during the three-month pilot.
Office visits to introduce the algorithms to nursing home
physicians were conducted using the six case-scenarios
presented to nursing staff. Feedback about the algorithms
from both physicians and nurses was positive, both
groups felt that the algorithms were user friendly and fea-
sible in the long-term care setting.
Additionally, the initial poor adherence to the algorithms
indicated that regularly scheduled on-site visits should be
another component of the intervention, serving as an im-
portant reminder or cue to the participants. Meetings with
the local champion for the study (usually the director of
nursing) to discuss barriers or obstacles to completing the
study were therefore held during the pilot. Feedback
about adherence to the protocol was given. Such follow
up visits were acceptable to staff and administrators as
they were not overly time consuming.
Phase III: methodological issues for the main trial
Overview
Campbell and colleagues state that this step addresses is-
sues normally posed by randomized trials, such as sample
size, inclusion and exclusion criteria, methods of rand-
omization, as well as the challenges of complex interven-
tions [15].
The main antibiotic trial uses a randomized matched pair
design where one of 11 pairs of nursing homes (matched
by size and case-mix), has been randomized to the clinical
algorithms and the other to usual management of pre-
sumptive urinary tract infections. Only free-standing,
community-based nursing homes are eligible i.e. those
representative of the majority of nursing homes in Canada
and the United States. To be eligible, nursing homes must
also: 1) have 100 or more residents (since the required
sample size of antibiotics courses will be achieved soon-
er); 2) have no stated policy for diagnosis or treatment of
urinary tract infections; 3) agree to refrain from introduc-
ing new management strategies for antibiotic utilization
or urinary tract infection during the study. The primary
outcome of this trial is the total number of antibiotic
courses prescribed. Other outcomes include 1) the pro-
portion of antibiotic courses prescribed for urinary indica-
tions, 2) rates of urine cultures ordered, 3) hospitalization
rates for urinary tract infections, and 4) mortality rates.
The last two outcomes are being measured to ensure that
the algorithms can safely be applied. Within a nursing
home, randomization of individual healthcare providers
to the algorithm likely would introduce bias due to con-
tamination. Therefore, for the quantitative component of
this study, the nursing home will serve as the unit of allo-
cation and analysis.
To conceal allocation, one nursing home in each pair was
arbitrarily assigned an even number (and the other odd)
by a hospital administrative assistant not associated with
the study or any of the investigators and who was blinded
to the nursing homes' identity. A statistician who is not as-
sociated with the study and who was unaware of the nurs-
ing home pairs, generated a list of 11 random numbers
using a random numbers table, one for each pair of nurs-
ing homes. The corresponding odd or even numbered
nursing home in each pair was assigned the intervention.
An absolute reduction in 20% of all antibiotic use, which
corresponds to a reduction in the proportion of antibiotic
prescriptions for urinary indications from 30% to 10%,
was considered the minimal clinically important effect
worth detecting. To detect this difference, for an alpha of
0.05 and 80% power, adjusting for the effect of within
cluster dependency, 4513 prescriptions need to be collect-
ed in total. This means that 20 or 10 pairs of nursing
homes will need to be followed for 10 months. Given the
potential for withdrawals of nursing homes, 22 homes
will be recruited.
A paired t-test will be used to analyse the within-pair dif-
ferences between the proportions of antibiotics prescribed
for urinary indications in matched pairs of nursing
homes. This way, the fact that the denominator of the pro-
portions is actually an outcome is taken into considera-
tion. Differences in rates of overall antibiotic use
(antibiotic courses per 1000 resident days) will be com-
pared using a paired t-test. Rates of antibiotic use for uri-
nary indications (antibiotic courses per 1000 resident
days and defined daily dosages/1000 resident days), rates
of urine cultures obtained (urine cultures per 1000 resi-
dent days), rates of hospitalization (per 1000 residentBMC Health Services Research 2002, 2 http://www.biomedcentral.com/1472-6963/2/13
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days), and overall mortality rates will be compared using
paired t-tests and Wilcoxon signed rank test. Logistic re-
gression analysis that adjusts for the effect of clustering
will be performed to adjust for potentially important co-
variates such as nursing home size, proportion of resi-
dents bed/wheelchair bound, and pharmacy automatic
stop dates.
Phase IV: promoting effective stability of the intervention, 
assessing for the existence of adverse effects
Qualitative studies to assess the attitudes and perceptions
of both nurses and physicians will help us understand the
key elements to maintaining sustainability should the in-
tervention prove to be successful in reducing antibiotic
use. We plan to conduct focus group studies for nursing
staff and semi-structured interviews amongst physicians
and directors of nursing care. If the intervention is not suc-
cessful, this qualitative approach may help explain the
barriers leading to failure of the intervention.
Although the trial itself is meant to examine the effective-
ness of the intervention, including adherence and adverse
effects, if the results demonstrate that the intervention can
reduce overall antibiotic use and is safe, one possibility is
to conduct a cohort study of the algorithms in nursing
homes over a large geographic area will be made.
Discussion
The application of the trial to improve antibiotic use in
nursing home residents to the framework demonstrates
that the framework is a useful resource for health services
researchers. Not surprisingly, the stages of the framework
have been used in previous studies of complex interven-
tions, even before the framework was published. One re-
cent example is the Rapid Early Action for Coronary
Treatment (REACT), a multi-component, community-
based educational intervention of community develop-
ment, public education, provider education, and patient
education (31). The description of the trial described in
this paper however allows for a focused assessment of the
components of this framework.
The pre-clinical phase of the antibiotic trial involved a
summary of the evidence needed to construct the algo-
rithms. This phase should include a systematic review of
the literature with respect to the intervention [32], a point
omitted in the pre-clinical phase description of the design
paper but discussed in the Medical Research Council pa-
per  [www.mrc.ac.uk/index/publications/publications-
electronic_publications.htm] described in the text [15]. It
was also evident that the preclinical and first phase cannot
be clearly demarcated, given that it was the modeling
study in phase I which actually determined if the interven-
tion had the potential to have the desired effect, the stated
aim of the preclinical phase [15].
The use of qualitative research to help define the interven-
tion was extremely valuable. Focus group studies helped
to accurately identify and anticipate barriers to the inter-
vention, even prior to the pilot study. Determining physi-
cians and nurses attitudes, beliefs, and behaviors toward
antibiotic use for urinary infections highlighted the im-
portance of nonspecific, non-urinary symptoms and the
key role of nurses in the process of antibiotic treatment of
asymptomatic bacteriuria in institutionalized older
adults. As specified in the framework, these findings illus-
trate the utility of using qualitative methods early in the
development of complex interventions. Focus groups and
semi-structured interviews will also be conducted at the
end of the main trial. We anticipate that such qualitative
data will help us identify strategies to sustain the algo-
rithms should the algorithms prove to be effective in re-
ducing antibiotic use [33,34].
Results of the questionnaires administered to nurses and
physicians used in developing the algorithms provided
convincing evidence about the need to target both order-
ing of urine cultures and antibiotic prescribing in order to
reduce overall antibiotic use. The particular importance of
introducing the algorithms to nurses in order to culturing
of urine was emphasized. This confirmed the qualitative
findings. It is notable that although the phases of the
framework are described as being sequential [15], compo-
nents of the frameworks might vary temporally, as exem-
plified by the qualitative and questionnaire data described
in phase I being collected prior to the actual development
of the algorithms.
The pilot study was instrumental in refining and introduc-
ing the algorithms. One of the most valuable aspects of
the pilot study was finding the optimal way to introduce
the algorithms to nurses and physicians. Perhaps more
emphasis could have been placed on strategies to intro-
duce the complex health interventions in the design
framework [15].
An important methodological issue for randomized trials
of complex health interventions is allocation conceal-
ment. This was a key consideration in the design and im-
plementation of the antibiotic trial. Empiric evidence
exists to suggest that failure to conceal allocation can re-
sult in larger biased estimates of effect than failure to
blind [35]. When a limited number of clusters are rand-
omized, such as in this trial, there is extra concern [36]. Al-
though it is often impossible to blind patients,
practitioners, and researchers to the intervention, it is al-
ways possible to conceal allocation [35]. Such issues are
well described in the Medical Research Council paper de-
scribed in the text [15].BMC Health Services Research 2002, 2 http://www.biomedcentral.com/1472-6963/2/13
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Sample size calculation is an important challenge in clus-
ter-randomized trials. Cluster randomization reduces
power and the sample size generally needs to be substan-
tially increased. Further elaboration on this topic in the
Phase III of the framework would be of benefit to re-
searchers.
Conclusion
The application of a randomized trial to optimize antibi-
otic use in nursing homes to the framework reported by
Campbell and colleagues demonstrated that the frame-
work is a useful resource for researchers embarking on a
clinical trial of a complex health intervention.
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